Milad J. Alasady

Statistics

Publications

Citations

120

H-Index

Active since

2014

Affiliations

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center(Current)

University of Maryland, Baltimore

Argonne National Laboratory

Northwestern University

Milad J. Alasady is an author at University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center specializing in molecular oncology, ligand binding, and medicine.

ORCID

Publications per year

2014–2023

Publications

Covalent Small Molecule Inhibitors of Ca2+-Bound S100B

Michael C. Cavalier, Adam D. Pierce, Paul T. Wilder et al. · Biochemistry · 2014 · 41 citations · Full text

Medicine, Molecular Biology, Oncology +15

HSF2 cooperates with HSF1 to drive a transcriptional program critical for the malignant state

Roger S. Smith, Seesha Takagishi, David R. Amici et al. · Science Advances · 2022 · 35 citations · Full text

Life Sciences, Molecular Biology, Oncology +17

Octopamine metabolically reprograms astrocytes to confer neuroprotection against α-synuclein

Andrew Shum, Sofia Zaichick, Gregory S. McElroy et al. · Proceedings of the National Academy of Sciences · 2023 · 18 citations · Full text

Life Sciences, Neurobiology, Neuroscience +17

Small Molecule Inhibitors of Ca2+-S100B Reveal Two Protein Conformations

Michael C. Cavalier, Mohd. Imran Ansari, Adam D. Pierce et al. · Journal of Medicinal Chemistry · 2016 · 15 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +13

Novel protein–inhibitor interactions in site 3 of Ca2+-bound S100B as discovered by X-ray crystallography

Michael C. Cavalier, Zephan Melville, Ehson Aligholizadeh et al. · Acta Crystallographica Section D Structural Biology · 2016 · 11 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 5